Olympus Announces Collaboration with Visiopharm for Cloud Image Analysis, Stereology and Easy-to-Use Microscopy APPs
CENTER VALLEY, Pa., June 24, 2013 – Olympus has announced a collaboration that allows users of its leading VS120 Virtual Slide System to access powerful quantitative microscopy software and workflow enhancements from Visiopharm (Hørsholm, Denmark) in the Cloud. Registered users who log on to the new Cloud software-as-a-service (SaaS) system receive immediate access to the latest version of Visiopharm's entire suite of image analysis and stereology software through a centralized remote server-based account. Visiopharm Cloud software will support a wide variety of research applications in fields as varied as oncology research, respiratory research, neuroscience and skeletal research.
Breast PgR-DAB, Pos Ratio (N, A). Image captured using Olympus VS120 Virtual Slide System and Visiopharm software.
The Olympus-Visiopharm collaboration also includes access to Visiopharm's APPCenter. The APPCenter has an extensive and growing library of Analysis Protocol Packages (APPs) which provide easy-to-use, standardized protocols for dozens of the most important and popular research microscopy image capture and analysis tasks. APPs can be “test-driven” in advance before the user makes a commitment, and each APP also can be modified quickly in collaboration with Visiopharm to meet individual research needs. Data from use of the APPs can be stored locally or on the Cloud.
“Olympus and Visiopharm have a long-standing and robust collaboration,” said Pia Rinta-Panttila, product manager at Olympus. “The unmatched user-friendliness and image quality of the Olympus VS120 system is perfectly matched with both Cloud and locally deployed image analysis and stereology tools from Visiopharm. Taken together, they open new doors for researchers using whole slide imaging, making it more flexible, cost-effective and simple.”
The modular VS120 system creates virtual slides - high-resolution digital images of complete specimens that can be stored electronically either on the Cloud or a central server for simultaneous viewing anywhere in the world, at a range of magnifications. The system is designed to provide outstanding performance for brightfield, darkfield and fluorescence microscopy, combined with precise color rendition and scanning. The VS120 allows automated scanning at 2x, 10x, 20x and 40x magnifications and Virtual Slides can be shared easily with fellow researchers over the Internet.
For more information on the Olympus VS120 Virtual Slide System and cost-effective, powerful Cloud image analysis, stereology and protocols from Visiopharm, contact Pia Rinta-Panttila, Olympus America Inc. Email: email@example.com, phone 484-896-5292, or visit www.olympusamerica.com/visiopharm.
About Olympus America Inc., Scientific Equipment Group
Olympus America Scientific Equipment Group provides innovative microscope imaging solutions for researchers, doctors, clinicians and educators. Olympus microscope systems offer unsurpassed optics, superior construction and system versatility to meet the ever-changing needs of microscopists, paving the way for future advances in life science.
Olympus is a precision technology leader, designing and delivering innovative solutions in its core business areas: Medical and Surgical Products, Life Science Imaging Systems, Industrial Measurement and Imaging Instruments and Cameras and Audio Products. Olympus works collaboratively with its customers and affiliates worldwide to leverage R&D investment in precision technology and manufacturing processes across diverse business lines. These include:
- Gastrointestinal endoscopes, accessories, and minimally invasive surgical products;
- Advanced research, clinical and educational microscopes and research and educational digital imaging systems;
- Industrial research, engineering, test, inspection and measuring instruments; and
- Digital cameras and voice recorders.
Olympus serves the healthcare field with integrated product solutions and financial, educational and consulting services that help customers to efficiently, reliably and more easily achieve exceptional results. Olympus develops breakthrough technologies with revolutionary product design and functionality for the consumer and professional photography markets, and also is the leader in gastrointestinal endoscopy and clinical and educational microscopes. For more information, visit www.olympusamerica.com.
Over the past 12 years, Visiopharm image analysis and stereology software has become the preferred Quantitative Digital Pathology solution for leading hospitals, biopharmaceutical companies, clinical researchers, and academic researchers all over the world. Visiopharm has more than 375 deployed systems worldwide and a large network of distribution and support partners, and is featured in over 450 scientific publications.
Olympus and VS are trademarks or registered trademarks of Olympus Corporation, Olympus America Inc. and/or their affiliates.
The Olympus VS120 is not for clinical diagnostic use in the United States.